Skip to main content
. 2019 Oct 1;8:e41239. doi: 10.7554/eLife.41239

Figure 2. The immigration of lymphocytes into pLNs and their egress into the lymphatic system is severely impaired in Lyve1;Spns2Δ/Δ mice.

(A) FACS analysis of CD4+ and CD8+ SP T-cells (left) and mature rec. B-cells (right) of lymph fluid isolated from the cisterna chyli of Spns2f/f and Lyve1;Spns2Δ/Δ mice. (B) Experimental flow-chart of short-terming homing assays to quantify lymphocyte immigration into pLNs. (C) FACS analysis of total congenic CD45.1+ cells in pLNs two hours upon injection of WT splenocytes into Spns2f/f and Lyve1;Spns2Δ/Δ mice. (D) Light microscopy of frozen sections of pLNs of Spns2f/f (left) and Lyve1;Spns2Δ/Δ (right) mice for PNAd+ HEVs (blue) counterstained for collagen-IV+ (brown). (E) FACS analysis of total CD45-/CD31+/PNAd+ high-endothelial cells isolated from pLNs of Spns2f/f and Lyve1;Spns2Δ/Δ mice. (F) Experimental flow-chart of homing assays to quantify lymphocyte egress from pLNs. (G) Total numbers of congenic eGFP+ cells in pLNs at 0 hr and 20 hr upon injection of anti-α4 / anti-αL antibodies into Spns2f/f and Lyve1;Spns2Δ/Δ mice. Each circle (A, C, E, G) represents an individual mouse; bars indicate the mean. Scale bars, 50 μm (D). **p<0.005; ***p<0.0005 (two-tailed unpaired Student’s t-test (A, C, E, G)). Data are representative for five mice per group pooled from two independent experiments (A) with n = 2 or n = 3 mice per group (A), for six mice per group (D) or are pooled from two (C, G) or three (E) independent experiments with n = 2, n = 3 or n = 4 mice per group.

Figure 2.

Figure 2—figure supplement 1. Spns2 is effectively deleted in LECs and HEVs of Lyve1;Spns2Δ/Δ mice.

Figure 2—figure supplement 1.

(A) Confocal microscopy of pLNs of Lyve1;tdTomato reporter mice for tdTOMATO+ (LYVE1-) expressing cells (red), PNAd+ (green) HEVs and Lyve-1+ (blue) LECs. (B) FACS analysis of CD45-/CD31+/PNAd+/Lyve-1- high-endothelial cells and CD45-/CD31+/PNAd-/Lyve-1+ LECs isolated from pLNs of tdTomatoSTOP-loxP control mice or Lyve1;tdTomato mice for tdTOMATO expression. (C) FACS analysis of CD45-/CD31+/PNAd+/Lyve-1- high-endothelial cells and CD45-/CD31+/PNAd-/Lyve-1+ LECs of pLNs of Spns2f/f and Lyve1;Spns2Δ/Δ mice. (D) Quantitative RT-PCR analysis of Spns2 mRNA in sorted LECs, HEVs (as in C) and of whole blood from Spns2f/f and Lyve1;Spns2Δ/Δ mice. (E) Confocal microscopy of whole mounts of iLNs isolated from embryos of E16.5 (top) and E18.5 (bottom) of WT C57BL/6 mice for MAdCAM-1 (green), PNAd (red) and Lyve-1 (blue) on high-endothelial cell progenitors and HEVs. Scale bars, 200 μm (A, left), 50 μm (A, right) and 20 μm (D). Data are representative for three mice per group (A), or are representative for two individual experiments (B–D) of pooled non-hematopoietic cells from 2x pLNs, 2x iLNs, 2x aLNs, 2x bLNs, 6x cervical LNs collected from five mice per group (B–D), or are representative for five analyzed embryos per group (E).